Verve Therapeutics
Biotechnology ResearchView the employees at
Verve Therapeutics-
Aaron Beach Senior Director - Internal Quality Control at Verve Therapeutics
-
Cambridge, Massachusetts, United States
-
Top 10%
Anson Le Research Associate at Verve Therapeutics-
Greater Boston
-
Rising Star
Lisa Kasiewicz Sr. Scientist, Formulation at Verve Therapeutics-
Cambridge, Massachusetts, United States
-
Rising Star
Cole Kehn Student at Northeastern University-
Boston, Massachusetts, United States
-
Rising Star
Paulina Page Graduate Student at Northeastern University | MS in Medicinal Chemistry and Drug Discovery-
Cambridge, Massachusetts, United States
-
Rising Star
Overview
Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially for heterozygous familial hypercholesterolemia, a potentially fatal genetic heart disease. In 2022, Verve was recognized as a "Best Places to Work" by the Boston Globe. Verve is headquartered in Boston, Massachusetts.
-